MyoKardia Raises $54M In Latest Discounted Biotech IPO
Venture capital-backed heart disease treatment developer MyoKardia raised $54.4 million Wednesday in an initial public offering priced below the expected range, becoming the latest in a series of health-related new issuers...To view the full article, register now.
Already a subscriber? Click here to view full article